Skip to Content
Merck
CN
  • Targeted cancer stem cell therapies start with proper identification of the target.

Targeted cancer stem cell therapies start with proper identification of the target.

Molecular cancer research : MCR (2010-02-11)
Erina Vlashi, Frank Pajonk
MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Calpain Inhibitor I, ≥97% (TLC), powder